Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Single and Multiple Ascending Dosing Administration of MF-300 in Healthy Participants

NCT07613684 is registered in ClinicalTrials.gov with Epirium Bio Inc. as lead sponsor.

NCT NCT07613684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07613684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Single and Multiple Ascending Dosing Administration of MF-300 in Healthy Participants
Lead sponsor
Epirium Bio Inc.
Phase
Phase 1
Overall status
Completed
Start date
December 20, 2024
Completion date
October 9, 2025
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers